Mesothelioma Cancer Centers
Brigham and Women's Hospital
Doctors Affiliated with this Treatment Facility
Also known as “The Brigham,” Brigham and Women’s Hospital is an internationally recognized leader in the health care and medical research fields. The 793-bed hospital serves as the teaching affiliate of the highly respected Harvard Medical School and is located in the heart of Boston’s medical district. Brigham and Women’s is also a partner in the Dana-Farber/Harvard Cancer Center, a collaboration of 13 separate cancer treatment centers.
Brigham and Women’s has ranked on U.S. News and World Report’s Honor Roll of American hospitals for the past 18 years; in 2010, the hospital ranked 11th. The hospital has a leading transplant center and is recognized for its clinical and research work in cardiovascular medicine, the neurosciences and its cancer care through the Dana-Farber/Brigham and Women’s Cancer Center. In fact, Brigham and Women’s Hospital and the Dana-Farber Cancer Institute are physically connected by bridges, allowing the two facilities to work in close collaboration.
Brigham and Women’s Hospital technically formed in 1980 with the merger of three prestigious Harvard-affiliated hospitals: Peter Bent Brigham Hospital, Robert Breck Brigham Hospital and Boston Hospital for Women. But the hospital’s history can actually be traced back to 1832, with the establishment of Boston Lying-In Hospital – one of the country’s first all-maternity facilities, which would later become Boston Hospital for Women.
Throughout their 180-year history, Brigham and Women’s facilities have consistently been at the forefront of medical advances. In 1847, Boston Lying-In Hospital became the first hospital ever to administer anesthesia during childbirth. In 1923, a doctor at Peter Bent Brigham Hospital performed the world’s first successful heart valve surgery on a 12-year-old girl. The world’s first successful human organ transplant was performed at Peter Bent Brigham in 1954, when a kidney was transplanted from one twin to another – a feat that earned the surgeon a Nobel Prize. In 1984, New England’s first heart transplant was performed at the newly-formed Brigham and Women’s Hospital. And in 2011, a Brigham and Women’s surgical team performed the United States’ first-ever full face transplant.
Mesothelioma Treatment at Brigham and Women’s Hospital
Located at Brigham and Women’s Hospital, the International Mesothelioma Program (IMP) is among the largest mesothelioma treatment programs in the world. Founded by Dr. David J. Sugarbaker, the IMP offers cutting-edge treatments to people suffering from pleural mesothelioma, a rare, asbestos-related cancer that strikes the lining of a person’s lungs.
As a research and treatment center, the IMP seeks to advance the latest medications and therapies for the treatment of mesothelioma, while also developing new screening tools so medical professionals are able to detect the disease earlier. Among the IMP’s extensive tools is a tumor bank, created in 1992, that contains more than 600 frozen mesothelioma samples that are used in the program’s genetic and clinical studies. The IMP also works internationally and seeks to create satellite centers in areas around the world that have seen high occurrences of mesothelioma.
When working with patients, IMP’s experts look closely at individuals’ work histories and life experiences to determine if they have been exposed to cancer-causing agents that may have caused mesothelioma. The IMP also provides counseling and emotional/spiritual support for its patients, and staff can also assist with issues like housing and financial needs.
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette
Brigham and Women’s Hospital – About Us.
Brigham and Women’s Hospital – International Mesothelioma Program (IMP).
Brigham and Women’s Hospital – About IMP.
Wikipedia – Brigham and Women’s Hospital.